secwatch.observer — SEC 8-K summary
======================================

Issuer:     Autonomix Medical, Inc. (AMIX)
CIK:        0001617867
Form:       8-K
Filed at:   2024-01-31T23:59:59+00:00
Accession:  0001683168-24-000570
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 3.02, 8.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Autonomix Medical closes $11.2M IPO, regains cardiology rights via $8M warrant deal
--------------------------------------------------------------------------------

- IPO closed Jan 26: 2,234,222 shares at $5.00, gross proceeds $11,171,110 before expenses.
- Regained exclusive worldwide cardiology rights from Impulse Medical in exchange for warrant to buy 1.6M shares at $0.001 per share.
- CEO Lori Bisson cites momentum and on-track first-in-human pancreatic cancer pain study this quarter.
- Warrant shares subject to lockup: 12.5% for 6 months, remainder for 12 months post-IPO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1617867/000168316824000570/0001683168-24-000570-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1617867/000168316824000570/autonomix_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-000570

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer